Platelets and the complement cascade in atherosclerosis

Frontiers in Physiology

Volumn 6, Issue MAR, 2015, Pages

  Patzelt, Johannes ^a   Verschoor, Admar ^b   Langer, Harald F ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Atherosclerosis; Complement system proteins; Inflammation; Innate immunity; Platelets

Indexed keywords

C REACTIVE PROTEIN; CD59 ANTIGEN; CHEMOKINE RECEPTOR CX3CR1; COMPLEMENT COMPONENT C5A RECEPTOR; FIBRINOGEN; FIBRINOGEN RECEPTOR; FRACTALKINE; LOW DENSITY LIPOPROTEIN RECEPTOR; MANNOSE BINDING LECTIN; P SELECTIN GLYCOPROTEIN LIGAND 1; PEXELIZUMAB; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLINOSITOL GLYCAN A; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR RECEPTOR GPIB ALPHA;

ATHEROSCLEROSIS; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CORONARY ARTERY DISEASE; DISEASE COURSE; ENDOTHELIUM CELL; GENETIC ASSOCIATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; MOLECULAR INTERACTION; MORBIDITY; MORTALITY; NONHUMAN; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PATHOGENESIS; PERIPHERAL VASCULAR DISEASE; PROTEIN EXPRESSION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE; THROMBOCYTE ADHESION;

EID: 84926489967     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2015.00049     Document Type: Review

References (96)

1. Aggarwal, R., Sestak, A. L., D'Sousa, A., Dillon, S. P., Namjou, B., and Scofield, R. H. (2010). Complete complement deficiency in a large cohort of familial systemic lupus erythematosus. Lupus 19, 52-57. doi: 10.1177/0961203309346508
2. Best, L. G., Davidson, M., North, K. E., MacCluer, J. W., Zhang, Y., Lee, E. T., et al. (2004). Prospective analysis of mannose-binding lectin genotypes and coronary artery disease in American Indians: the strong heart study. Circulation 109, 471-475. doi: 10.1161/01.CIR.0000109757.95461.10
3. Bhatia, V. K., Yun, S., Leung, V., Grimsditch, D. C., Benson, G. M., Botto, M. B., et al. (2007). Complement C1q reduces early atherosclerosis in low-density lipoprotein receptor-deficient mice. Am. J. Pathol. 170, 416-426. doi: 10.2353/ajpath.2007.060406
4. Bombeli, T., Schwartz, B. R., and Harlan, J. M. (1998). Adhesion of activated platelets to endothelial cells: evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), alphavbeta3 integrin, and GPIbalpha. J. Exp. Med. 187, 329-339. doi: 10.1084/jem.187.3.329
5. Buono, C., Come, C. E., Witztum, J. L., Maguire, G. F., Connelly, P. W., Carroll, M., et al. (2002). Influence of C3 deficiency on atherosclerosis. Circulation 105, 3025-3031. doi: 10.1161/01.CIR.0000019584.04929.83
6. Burger, P. C., and Wagner, D. D. (2003). Platelet P-selectin facilitates atherosclerotic lesion development. Blood 101, 2661-2666. doi: 10.1182/blood-2002-07-2209
7. Cipollone, F., Mezzetti, A., Porreca, E., Di Febbo, C., Nutini, M., Fazia, M., et al. (2002). Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy. Circulation 106, 399-402. doi: 10.1161/01.CIR.0000025419.95769.F0
8. Del Conde, I., Cruz, M. A., Zhang, H., Lopez, J. A., and Afshar-Kharghan, V. (2005). Platelet activation leads to activation and propagation of the complement system. J. Exp. Med. 201, 871-879. doi: 10.1084/jem.20041497
9. Dole, V. S., Bergmeier, W., Patten, I. S., Hirahashi, J., Mayadas, T. N., and Wagner, D. D. (2007). PSGL-1 regulates platelet P-selectin-mediated endothelial activation and shedding of P-selectin from activated platelets. Thromb. Haemost. 98, 806-812.
10. Ferroni, P., Basili, S., Santilli, F., and Davi, G. (2006). Low-density lipoprotein-lowering medication and platelet function. Pathophysiol. Haemost. Thromb. 35, 346-354. doi: 10.1159/000093226
11. Frenette, P. S., Denis, C. V., Weiss, L., Jurk, K., Subbarao, S., Kehrel, B., et al. (2000). P-Selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions in vivo. J. Exp. Med. 191, 1413-1422. doi: 10.1084/jem.191.8.1413
12. Gadjeva, M., Verschoor, A., Brockman, M. A., Jezak, H., Shen, L. M., Knipe, D. M., et al. (2002). Macrophage-derived complement component C4 can restore humoral immunity in C4-deficient mice. J. Immunol. 169, 5489-5495. doi: 10.4049/jimmunol.169.10.5489
13. Gawaz, M., Langer, H., and May, A. E. (2005). Platelets in inflammation and atherogenesis. J. Clin. Invest. 115, 3378-3384. doi: 10.1172/JCI27196
14. Gawaz, M., Neumann, F. J., Dickfeld, T., Reininger, A., Adelsberger, H., Gebhardt, A., et al. (1997). Vitronectin receptor (alpha(v)beta3) mediates platelet adhesion to the luminal aspect of endothelial cells: implications for reperfusion in acute myocardial infarction. Circulation 96, 1809-1818. doi: 10.1161/01.CIR.96.6.1809
15. Gawaz, M., Stellos, K., and Langer, H. F. (2008). Platelets modulate atherogenesis and progression of atherosclerotic plaques via interaction with progenitor and dendritic cells. J. Thromb. Haemost. 6, 235-242. doi: 10.1111/j.1538-7836.2007.02867.x
16. Geertinger, P., and Sorensen, H. (1970). Complement as a factor in arteriosclerosis. Acta Pathol. Microbiol. Scand. A 78, 284-288.
17. Granger, C. B., Mahaffey, K. W., Weaver, W. D., Theroux, P., Hochman, J. S., Filloon, T. G., et al. (2003). Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial. Circulation 108, 1184-1190. doi: 10.1161/01.CIR.0000087447.12918.85
18. Gruner, S., Prostredna, M., Schulte, V., Krieg, T., Eckes, B., Brakebusch, C., et al. (2003). Multiple integrin-ligand interactions synergize in shear-resistant platelet adhesion at sites of arterial injury in vivo. Blood 102, 4021-4027. doi: 10.1182/blood-2003-05-1391
19. Gushiken, F. C., Han, H., Li, J., Rumbaut, R. E., and Afshar-Kharghan, V. (2009). Abnormal platelet function in C3-deficient mice. J. Thromb. Haemost. 7, 865-870. doi: 10.1111/j.1538-7836.2009.03334.x
20. Hamad, O. A., Ekdahl, K. N., Nilsson, P. H., Andersson, J., Magotti, P., Lambris, J. D., et al. (2008). Complement activation triggered by chondroitin sulfate released by thrombin receptor-activated platelets. J. Thromb. Haemost. 6, 1413-1421. doi: 10.1111/j.1538-7836.2008.03034.x
21. Hamad, O. A., Nilsson, P. H., Wouters, D., Lambris, J. D., Ekdahl, K. N., and Nilsson, B. (2010). Complement component C3 binds to activated normal platelets without preceding proteolytic activation and promotes binding to complement receptor 1. J. Immunol. 184, 2686-2692. doi: 10.4049/jimmunol.0902810
22. Hegele, R. A., Ban, M. R., Anderson, C. M., and Spence, J. D. (2000). Infection-susceptibility alleles of mannose-binding lectin are associated with increased carotid plaque area. J. Investig. Med. 48, 198-202.
23. Huo, Y., Schober, A., Forlow, S. B., Smith, D. F., Hyman, M. C., Jung, S., et al. (2003). Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat. Med. 9, 61-67. doi: 10.1038/nm810
24. Inoue, O., Suzuki-Inoue, K., Dean, W. L., Frampton, J., and Watson, S. P. (2003). Integrin alpha2beta1 mediates outside-in regulation of platelet spreading on collagen through activation of Src kinases and PLCgamma2. J. Cell Biol. 160, 769-780. doi: 10.1083/jcb.200208043
25. Investigators, A. A., Armstrong, P. W., Granger, C. B., Adams, P. X., Hamm, C., Holmes, D., et al. (2007). Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial. JAMA 297, 43-51. doi: 10.1001/jama.297.1.43
26. Jonsson, G., Truedsson, L., Sturfelt, G., Oxelius, V. A., Braconier, J. H., and Sjoholm, A. G. (2005). Hereditary C2 deficiency in Sweden: frequent occurrence of invasive infection, atherosclerosis, and rheumatic disease. Medicine (Baltimore). 84, 23-34. doi: 10.1097/01.md.0000152371.22747.1e
27. Karshovska, E., Zhao, Z., Blanchet, X., Schmitt, M. M., Bidzhekov, K., Soehnlein, O., et al. (2015). Hyperreactivity of junctional adhesion molecule a-deficient platelets accelerates atherosclerosis in hyperlipidemic mice. Circ. Res. 116, 587-599. doi: 10.1161/CIRCRESAHA.116.304035
28. Koyama, H., Maeno, T., Fukumoto, S., Shoji, T., Yamane, T., Yokoyama, H., et al. (2003). Platelet P-selectin expression is associated with atherosclerotic wall thickness in carotid artery in humans. Circulation 108, 524-529. doi: 10.1161/01.CIR.0000081765.88440.51
29. Laine, P., Pentikainen, M. O., Wurzner, R., Penttila, A., Paavonen, T., Meri, S., et al. (2002). Evidence for complement activation in ruptured coronary plaques in acute myocardial infarction. Am. J. Cardiol. 90, 404-408. doi: 10.1016/S0002-9149(02)02498-0
30. Langer, H. F., and Chavakis, T. (2009). Leukocyte-endothelial interactions in inflammation. J. Cell. Mol. Med. 13, 1211-1220. doi: 10.1111/j.1582-4934.2009.00811.x
31. Langer, H. F., and Gawaz, M. (2008). Platelet-vessel wall interactions in atherosclerotic disease. Thromb. Haemost. 99, 480-486. doi: 10.1160/TH07-11-0685
32. Langer, H. F., Choi, E. Y., Zhou, H., Schleicher, R., Chung, K. J., Tang, Z., et al. (2012). Platelets contribute to the pathogenesis of experimental autoimmune encephalomyelitis. Circ. Res. 110, 1202-1210. doi: 10.1161/CIRCRESAHA.111.256370
33. Langer, H. F., Daub, K., Braun, G., Schonberger, T., May, A. E., Schaller, M., et al. (2007). Platelets recruit human dendritic cells via Mac-1/JAM-C interaction and modulate dendritic cell function in vitro. Arterioscler. Thromb. Vasc. Biol. 27, 1463-1470. doi: 10.1161/ATVBAHA.107.141515
34. Lewis, M. J., Malik, T. H., Ehrenstein, M. R., Boyle, J. J., Botto, M., and Haskard, D. O. (2009). Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 120, 417-426. doi: 10.1161/CIRCULATIONAHA.109.868158
35. Ley, K., Laudanna, C., Cybulsky, M. I., and Nourshargh, S. (2007). Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 7, 678-689. doi: 10.1038/nri2156
36. Li, K., Sacks, S. H., and Zhou, W. (2007). The relative importance of local and systemic complement production in ischaemia, transplantation and other pathologies. Mol. Immunol. 44, 3866-3874. doi: 10.1016/j.molimm.2007.06.006
37. Madsen, H. O., Videm, V., Svejgaard, A., Svennevig, J. L., and Garred, P. (1998). Association of mannose-binding-lectin deficiency with severe atherosclerosis. Lancet 352, 959-960. doi: 10.1016/S0140-6736(05)61513-9
38. Manthey, H. D., Thomas, A. C., Shiels, I. A., Zernecke, A., Woodruff, T. M., Rolfe, B., et al. (2011). Complement C5a inhibition reduces atherosclerosis in ApoE-/- mice. FASEB J. 25, 2447-2455. doi: 10.1096/fj.10-174284
39. Martel, C., Cointe, S., Maurice, P., Matar, S., Ghitescu, M., Theroux, P., et al. (2011). Requirements for membrane attack complex formation and anaphylatoxins binding to collagen-activated platelets. PLoS ONE 6:e18812. doi: 10.1371/journal.pone.0018812
40. Massberg, S., Brand, K., Gruner, S., Page, S., Muller, E., Muller, I., et al. (2002). A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J. Exp. Med. 196, 887-896. doi: 10.1084/jem.20012044
41. Massberg, S., Gawaz, M., Gruner, S., Schulte, V., Konrad, I., Zohlnhofer, D., et al. (2003). A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo. J. Exp. Med. 197, 41-49. doi: 10.1084/jem.20020945
42. Muscari, A., Bozzoli, C., Gerratana, C., Zaca, F., Rovinetti, C., Zauli, D., et al. (1988). Association of serum IgA and C4 with severe atherosclerosis. Atherosclerosis 74, 179-186. doi: 10.1016/0021-9150(88)90204-3
43. Nicholson-Weller, A., Burge, J., Fearon, D. T., Weller, P. F., and Austen, K. F. (1982). Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system. J. Immunol. 129, 184-189.
44. Niculescu, F., and Rus, H. (2004). The role of complement activation in atherosclerosis. Immunol. Res. 30, 73-80. doi: 10.1385/IR:30:1:073
45. Niculescu, F., Rus, H. G., and Vlaicu, R. (1987). Immunohistochemical localization of C5b-9, S-protein, C3d and apolipoprotein B in human arterial tissues with atherosclerosis. Atherosclerosis 65, 1-11. doi: 10.1016/0021-9150(87)90002-5
46. Niculescu, F., Rus, H., Cristea, A., and Vlaicu, R. (1985). Localization of the terminal C5b-9 complement complex in the human aortic atherosclerotic wall. Immunol. Lett. 10, 109-114. doi: 10.1016/0165-2478(85)90185-3
47. Nityanand, S., Truedsson, L., Mustafa, A., Bergmark, C., and Lefvert, A. K. (1999). Circulating immune complexes and complement C4 null alleles in patients in patients operated on for premature atherosclerotic peripheral vascular disease. J. Clin. Immunol. 19, 406-413. doi: 10.1023/A:1020506901117
48. Oksjoki, R., Jarva, H., Kovanen, P. T., Laine, P., Meri, S., and Pentikainen, M. O. (2003). Association between complement factor H and proteoglycans in early human coronary atherosclerotic lesions: implications for local regulation of complement activation. Arterioscler. Thromb. Vasc. Biol. 23, 630-636. doi: 10.1161/01.ATV.0000057808.91263.A4
49. Oksjoki, R., Kovanen, P. T., Mayranpaa, M. I., Laine, P., Blom, A. M., Meri, S., et al. (2007). Complement regulation in human atherosclerotic coronary lesions. Immunohistochemical evidence that C4b-binding protein negatively regulates the classical complement pathway, and that C5b-9 is formed via the alternative complement pathway. Atherosclerosis 192, 40-48. doi: 10.1016/j.atherosclerosis.2006.06.013
50. Patzelt, J., and Langer, H. F. (2012). Platelets in angiogenesis. Curr. Vasc. Pharmacol. 10, 570-577. doi: 10.2174/157016112801784648
51. Patzelt, J., Mueller, K. A., Breuning, S., Karathanos, A., Schleicher, R., Seizer, P., et al. (2014). Expression of anaphylatoxin receptors on platelets in patients with coronary heart disease. Atherosclerosis 238, 289-295. doi: 10.1016/j.atherosclerosis.2014.12.002
52. Peerschke, E. I., and Ghebrehiwet, B. (1997). C1q augments platelet activation in response to aggregated Ig. J. Immunol. 159, 5594-5598.
53. Peerschke, E. I., and Ghebrehiwet, B. (2001). Human blood platelet gC1qR/p33. Immunol. Rev. 180, 56-64. doi: 10.1034/j.1600-065X.2001.1800105.x
54. Peerschke, E. I., Minta, J. O., Zhou, S. Z., Bini, A., Gotlieb, A., Colman, R. W., et al. (2004). Expression of gC1q-R/p33 and its major ligands in human atherosclerotic lesions. Mol. Immunol. 41, 759-766. doi: 10.1016/j.molimm.2004.04.020
55. Persson, L., Boren, J., Robertson, A. K., Wallenius, V., Hansson, G. K., and Pekna, M. (2004). Lack of complement factor C3, but not factor B, increases hyperlipidemia and atherosclerosis in apolipoprotein E-/- low-density lipoprotein receptor-/- mice. Arterioscler. Thromb. Vasc. Biol. 24, 1062-1067. doi: 10.1161/01.ATV.0000127302.24266.40
56. Polley, M. J., and Nachman, R. L. (1983). Human platelet activation by C3a and C3a des-arg. J. Exp. Med. 158, 603-615. doi: 10.1084/jem.158.2.603
57. Ricklin, D., Hajishengallis, G., Yang, K., and Lambris, J. D. (2010). Complement: a key system for immune surveillance and homeostasis. Nat. Immunol. 11, 785-797. doi: 10.1038/ni.1923
58. Ross, R. (1999). Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340, 115-126. doi: 10.1056/NEJM199901143400207
59. Santoso, S., Sachs, U. J., Kroll, H., Linder, M., Ruf, A., Preissner, K. T., et al. (2002). The junctional adhesion molecule 3 (JAM-3) on human platelets is a counterreceptor for the leukocyte integrin Mac-1. J. Exp. Med. 196, 679-691. doi: 10.1084/jem.20020267
60. Schober, A., Manka, D., von Hundelshausen, P., Huo, Y., Hanrath, P., Sarembock, I. J., et al. (2002). Deposition of platelet RANTES triggering monocyte recruitment requires P-selectin and is involved in neointima formation after arterial injury. Circulation 106, 1523-1529. doi: 10.1161/01.CIR.0000028590.02477.6F
61. Schulz, C., Schafer, A., Stolla, M., Kerstan, S., Lorenz, M., von Bruhl, M. L., et al. (2007). Chemokine fractalkine mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood: a critical role for P-selectin expressed on activated platelets. Circulation 116, 764-773. doi: 10.1161/CIRCULATIONAHA.107.695189
62. Seifert, P. S., Hugo, F., Hansson, G. K., and Bhakdi, S. (1989). Prelesional complement activation in experimental atherosclerosis. Terminal C5b-9 complement deposition coincides with cholesterol accumulation in the aortic intima of hypercholesterolemic rabbits. Lab. Invest. 60, 747-754.
63. Shagdarsuren, E., Bidzhekov, K., Mause, S. F., Simsekyilmaz, S., Polakowski, T., Hawlisch, H., et al. (2010). C5a receptor targeting in neointima formation after arterial injury in atherosclerosis-prone mice. Circulation 122, 1026-1036. doi: 10.1161/CIRCULATIONAHA.110.954370
64. Shpilberg, O., Rabi, I., Schiller, K., Walden, R., Harats, D., Tyrrell, K. S., et al. (2002). Patients with Glanzmann thrombasthenia lacking platelet glycoprotein alpha(IIb)beta(3) (GPIIb/IIIa) and alpha(v)beta(3) receptors are not protected from atherosclerosis. Circulation 105, 1044-1048. doi: 10.1161/hc0902.104676
65. Siegel-Axel, D., Daub, K., Seizer, P., Lindemann, S., and Gawaz, M. (2008). Platelet lipoprotein interplay: trigger of foam cell formation and driver of atherosclerosis. Cardiovasc. Res. 78, 8-17. doi: 10.1093/cvr/cvn015
66. Sims, P. J., and Wiedmer, T. (1991). The response of human platelets to activated components of the complement system. Immunol. Today 12, 338-342. doi: 10.1016/0167-5699(91)90012-I
67. Speidl, W. S., Exner, M., Amighi, J., Kastl, S. P., Zorn, G., Maurer, G., et al. (2005). Complement component C5a predicts future cardiovascular events in patients with advanced atherosclerosis. Eur. Heart J. 26, 2294-2299. doi: 10.1093/eurheartj/ehi339
68. Speidl, W. S., Kastl, S. P., Huber, K., and Wojta, J. (2011a). Complement in atherosclerosis: friend or foe? J. Thromb. Haemost. 9, 428-440. doi: 10.1111/j.1538-7836.2010.04172.x
69. Speidl, W. S., Kastl, S. P., Hutter, R., Katsaros, K. M., Kaun, C., Bauriedel, G., et al. (2011b). The complement component C5a is present in human coronary lesions in vivo and induces the expression of MMP-1 and MMP-9 in human macrophages in vitro. FASEB J. 25, 35-44. doi: 10.1096/fj.10-156083
70. Stahl, A. L., Vaziri-Sani, F., Heinen, S., Kristoffersson, A. C., Gydell, K. H., Raafat, R., et al. (2008). Factor H dysfunction in patients with atypical hemolytic uremic syndrome contributes to complement deposition on platelets and their activation. Blood 111, 5307-5315. doi: 10.1182/blood-2007-08-106153
71. Stellos, K., Sauter, R., Fahrleitner, M., Grimm, J., Stakos, D., Emschermann, F., et al. (2012). Binding of oxidized low-density lipoprotein on circulating platelets is increased in patients with acute coronary syndromes and induces platelet adhesion to vascular wall in vivo-brief report. Arterioscler. Thromb. Vasc. Biol. 32, 2017-2020. doi: 10.1161/ATVBAHA.111.244707
72. Strassel, C., Hechler, B., Bull, A., Gachet, C., and Lanza, F. (2009). Studies of mice lacking the GPIb-V-IX complex question the role of this receptor in atherosclerosis. J. Thromb. Haemost. 7, 1935-1938. doi: 10.1111/j.1538-7836.2009.03608.x
73. Strassel, C., Nonne, C., Eckly, A., David, T., Leon, C., Freund, M., et al. (2007). Decreased thrombotic tendency in mouse models of the Bernard-Soulier syndrome. Arterioscler. Thromb. Vasc. Biol. 27, 241-247. doi: 10.1161/01.ATV.0000251992.47053.75
74. Testa, L., Meco, M., Cirri, S., and Bedogni, F. (2011). Pexelizumab and survival in cardiac surgery. HSR Proc. Intensive Care Cardiovasc. Anesth. 3, 23-24.
75. Thomas, T. C., Rollins, S. A., Rother, R. P., Giannoni, M. A., Hartman, S. L., Elliott, E. A., et al. (1996). Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv. Mol. Immunol. 33, 1389-1401. doi: 10.1016/S0161-5890(96)00078-8
76. Torzewski, M., Klouche, M., Hock, J., Messner, M., Dorweiler, B., Torzewski, J., et al. (1998). Immunohistochemical demonstration of enzymatically modified human LDL and its colocalization with the terminal complement complex in the early atherosclerotic lesion. Arterioscler. Thromb. Vasc. Biol. 18, 369-378. doi: 10.1161/01.ATV.18.3.369
77. Totani, L., and Evangelista, V. (2010). Platelet-leukocyte interactions in cardiovascular disease and beyond. Arterioscler. Thromb. Vasc. Biol. 30, 2357-2361. doi: 10.1161/ATVBAHA.110.207480
78. van der Net, J. B., Oosterveer, D. M., Versmissen, J., Defesche, J. C., Yazdanpanah, M., Aouizerat, B. E., et al. (2008). Replication study of 10 genetic polymorphisms associated with coronary heart disease in a specific high-risk population with familial hypercholesterolemia. Eur. Heart J. 29, 2195-2201. doi: 10.1093/eurheartj/ehn303
79. van Gils, J. M., Zwaginga, J. J., and Hordijk, P. L. (2009). Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases. J. Leukoc. Biol. 85, 195-204. doi: 10.1189/jlb.0708400
80. Verrier, E. D., Shernan, S. K., Taylor, K. M., Van de Werf, F., Newman, M. F., Chen, J. C., et al. (2004). Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: a randomized trial. JAMA 291, 2319-2327. doi: 10.1001/jama.291.19.2319
81. Verschoor, A., Brockman, M. A., Gadjeva, M., Knipe, D. M., and Carroll, M. C. (2003). Myeloid C3 determines induction of humoral responses to peripheral herpes simplex virus infection. J. Immunol. 171, 5363-5371. doi: 10.4049/jimmunol.171.10.5363
82. Verschoor, A., Brockman, M. A., Knipe, D. M., and Carroll, M. C. (2001). Cutting edge: myeloid complement C3 enhances the humoral response to peripheral viral infection. J. Immunol. 167, 2446-2451. doi: 10.4049/jimmunol.167.5.2446
83. Verschoor, A., and Carroll, M. C. (2004). "Complement and its receptors in infection," in The Innate Immune Response to Infection, eds S. H. E. Kaufmann, R. Medzhitov and S. Gordon (Washington, DC: American Society for Microbiology Press), 219-240. doi: 10.1128/9781555817671.ch11
84. Verschoor, A., and Langer, H. F. (2013). Crosstalk between platelets and the complement system in immune protection and disease. Thromb. Haemost. 110, 910-919. doi: 10.1160/TH13-02-0102
85. Verschoor, A., Neuenhahn, M., Navarini, A. A., Graef, P., Plaumann, A., Seidlmeier, A., et al. (2011). A platelet-mediated system for shuttling blood-borne bacteria to CD8alpha+ dendritic cells depends on glycoprotein GPIb and complement C3. Nat. Immunol. 12, 1194-1201. doi: 10.1038/ni.2140
86. Vik, D. P., and Fearon, D. T. (1987). Cellular distribution of complement receptor type 4 (CR4): expression on human platelets. J. Immunol. 138, 254-258.
87. Vlaicu, R., Rus, H. G., Niculescu, F., and Cristea, A. (1985). Quantitative determinations of immunoglobulins and complement components in human aortic atherosclerotic wall. Med. Interne 23, 29-35.
88. von Hundelshausen, P., and Schmitt, M. M. (2014). Platelets and their chemokines in atherosclerosis-clinical applications. Front. Physiol. 5:294. doi: 10.3389/fphys.2014.00294
89. von Hundelshausen, P., and Weber, C. (2007). Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ. Res. 100, 27-40. doi: 10.1161/01.RES.0000252802.25497.b7
90. von Hundelshausen, P., Koenen, R. R., and Weber, C. (2009). Platelet-mediated enhancement of leukocyte adhesion. Microcirculation 16, 84-96. doi: 10.1080/10739680802564787
91. Wagner, D. D., and Frenette, P. S. (2008). The vessel wall and its interactions. Blood 111, 5271-5281. doi: 10.1182/blood-2008-01-078204
92. Walport, M. J. (2001). Complement. First of two parts. N. Engl. J. Med. 344, 1058-1066. doi: 10.1056/NEJM200104053441406
93. Wautier, J. L., Souchon, H., Reid, K. B., Peltier, A. P., and Caen, J. P. (1977). Studies on the mode of reaction of the first component of complement with platelets: interaction between the collagen-like portion of C1q and platelets. Immunochemistry 14, 763-766. doi: 10.1016/0019-2791(77)90351-2
94. Weber, C., and Springer, T. A. (1997). Neutrophil accumulation on activated, surface-adherent platelets in flow is mediated by interaction of Mac-1 with fibrinogen bound to alphaIIbbeta3 and stimulated by platelet-activating factor. J. Clin. Invest. 100, 2085-2093. doi: 10.1172/JCI119742
95. Weber, K. S., Alon, R., and Klickstein, L. B. (2004). Sialylation of ICAM-2 on platelets impairs adhesion of leukocytes via LFA-1 and DC-SIGN. Inflammation 28, 177-188. doi: 10.1023/B:IFLA.0000049042.73926.eb
96. Yasojima, K., Schwab, C., McGeer, E. G., and McGeer, P. L. (2001). Complement components, but not complement inhibitors, are upregulated in atherosclerotic plaques. Arterioscler. Thromb. Vasc. Biol. 21, 1214-1219. doi: 10.1161/hq0701.092160